{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:44:43Z","timestamp":1786995883084,"version":"build-2736575974"},"reference-count":278,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.preteyeres.2025.101421","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:05:19Z","timestamp":1764835519000},"page":"101421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-4771","authenticated-orcid":false,"given":"Christiana","family":"Dinah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieh","family":"Esmaeelpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra V.","family":"Rachitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion R.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2025.101421_bib1","article-title":"A clinical and preclinical assessment of clinical trials for dry age-related macular degeneration. Ophthalmol","volume":"2","author":"Abidi","year":"2022","journal-title":"Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/tvst.7.5.32","article-title":"Home monitoring of retinal sensitivity on a tablet device in intermediate age-related macular degeneration","volume":"7","author":"Adams","year":"2018","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/jov.21.12.5","article-title":"A comparison of reading, in people with simulated and actual central vision loss, with static text, horizontally scrolling text, and rapid serial visual presentation","volume":"21","author":"Akthar","year":"2021","journal-title":"J. Vis."},{"key":"10.1016\/j.preteyeres.2025.101421_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40942-020-00217-0","article-title":"Test-retest variability of microperimetry in geographic atrophy","volume":"6","author":"Alibhai","year":"2020","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2025.101421_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-024-00624-7","article-title":"Evaluating the reliability of a microperimetry-based method for assessing visual function in the junctional zone of geographic atrophy lesions","volume":"11","author":"Alibhai","year":"2025","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2025.101421_bib6","article-title":"Topline results from Alkeus Pharmaceuticals\u2019 study of oral gildeuretinol demonstrate significant trend in slowing GA progression and visual function improvement.","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4274\/tjo.galenos.2021.27985","article-title":"Fixation stability and preferred retinal locus in advanced age-related macular degeneration","volume":"52","author":"Altinbay","year":"2022","journal-title":"Turk. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib8","first-page":"4594","article-title":"Association of baseline central subfield ellipsoid zone integrity with baseline visual acuity and future vision loss in the GATHER clinical trials","volume":"66","author":"Amine","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.64.14.7","article-title":"Evaluating contrast sensitivity in early and intermediate age-related macular degeneration with the quick contrast sensitivity function","volume":"64","author":"Anders","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/bjo-2024-325310","article-title":"Expert CONsensus on Visual Evaluation in Retinal disease manaGEment: the CONVERGE study","volume":"109","author":"Anderson","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ophtha.2024.11.017","article-title":"Visual loss in geographic atrophy: learnings from the lampalizumab trials","volume":"132","author":"Anegondi","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib14","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1159\/000535375","article-title":"The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: design and baseline characteristics \u2013 OMEGA report 1","volume":"66","author":"Ansari","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100886","article-title":"Validation and repeatability of differential light sensitivity measurements with the novel MAIA microperimetry device","author":"Ansari","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib21","first-page":"2252","article-title":"Geographic atrophy: a prospective longitudinal analysis of macular sensitivity using microperimetry","volume":"64","author":"Arunachalam","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib22","unstructured":"Astellas Pharma, 2023a. Iveric bio announces positive 24-month topline results from phase 3 study of IZERVAY\u2122 (avacincaptad pegol intravitreal solution) for geographic atrophy. https:\/\/newsroom.astellas.us\/2023-09-18-Iveric-Bio-Announces-Positive-24-Month-Topline-Results-from-Phase-3-Study-of-IZERVAY-TM-avacincaptad-pegol-intravitreal-solution-for-Geographic-Atrophy. (Accessed 29 May 2025)."},{"key":"10.1016\/j.preteyeres.2025.101421_bib303","unstructured":"Astellas Pharma, 2023b. Iveric Bio receives U.S. FDA approval for IZERVAY\u2122 (avacincaptad pegol intravitreal solution), a new treatment for geographic atrophy. https:\/\/www.astellas.com\/en\/news\/28281 (accessed 29 May 2025)."},{"key":"10.1016\/j.preteyeres.2025.101421_bib23","first-page":"S2","article-title":"Geographic atrophy: mechanism of disease, pathophysiology, and role of the complement system","volume":"29","author":"Bakri","year":"2023","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.preteyeres.2025.101421_bib24","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.2147\/OPTH.S488559","article-title":"Characterizing patient perceptions of living with geographic atrophy: the Global Geographic Atrophy Insights survey","volume":"18","author":"Bakri","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19413-z","article-title":"Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning","volume":"12","author":"Balaskas","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib26","series-title":"EURETINA 2024. Barcelona, Spain","first-page":"19","article-title":"Functional consequences of avacincaptad pegol treatment in the GATHER trials","author":"Bandello","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib27","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3390\/jcm12134371","article-title":"Making sense of composite endpoints in clinical research","volume":"12","author":"Baracaldo-Santamar\u00eda","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib28","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1038\/s41598-021-83716-w","article-title":"Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration","volume":"11","author":"Barkana","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/OPX.0000000000001229","article-title":"Visual acuity is not the best at the preferred retinal locus in people with macular disease","volume":"95","author":"Bernard","year":"2018","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/biomedicines11061548","article-title":"Methodological appraisal of phase 3 clinical trials in geographic atrophy","volume":"11","author":"Biarn\u00e9s","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2025.101421_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14737159.4.5.693","article-title":"Surrogate electroretinographic markers for assessing therapeutic efficacy in the retina","volume":"4","author":"Birch","year":"2004","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.preteyeres.2025.101421_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/eye.2015.94","article-title":"Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements","volume":"29","author":"Bokinni","year":"2015","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib33","first-page":"299","article-title":"Functional outcomes and quality of life in geographic atrophy in the clinical setting. Ophthalmol","volume":"9","author":"Borkar","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","article-title":"LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the Lumithera Valeda Light Delivery System","volume":"44","author":"Boyer","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.13.12.27","article-title":"Clinically meaningful change estimates for the National Eye Institute Visual Function Questionnaire-25 in patients with diabetic macular edema","volume":"13","author":"Bressler","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.0326","article-title":"Selecting and implementing patient-reported outcome and experience measures to assess health system performance","volume":"3","author":"Bull","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.preteyeres.2025.101421_bib37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/OPTH.S246245","article-title":"Multimodal evaluation of visual function in geographic atrophy versus normal eyes","volume":"14","author":"Burguera-Gim\u00e9nez","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/18.1.8","article-title":"Comparing performance on the MNREAD iPad application with the MNREAD acuity chart","volume":"18","author":"Calabr\u00e8se","year":"2018","journal-title":"J. Vis."},{"key":"10.1016\/j.preteyeres.2025.101421_bib39","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41433-020-01221-2","article-title":"Comparison of the handheld RETeval ERG system with a routine ERG system in healthy adults and in paediatric patients","volume":"35","author":"Carter","year":"2021","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40123-021-00352-3","article-title":"Seeing beyond anatomy: quality of life with geographic atrophy","volume":"10","author":"Caswell","year":"2021","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101421_bib41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","article-title":"Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","article-title":"Progression from early\/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors","volume":"4","author":"Chakravarthy","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2025.02.012","article-title":"Visual function benefit after treatment with pegcetacoplan: microperimetry analysis from the phase 3 OAKS trial","volume":"273","author":"Chakravarthy","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/PROM.S178344","article-title":"Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality","volume":"10","author":"Chang","year":"2019","journal-title":"Patient Relat. Outcome Meas."},{"key":"10.1016\/j.preteyeres.2025.101421_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100351","article-title":"Macular sensitivity endpoints in geographic atrophy: exploratory analysis of Chroma and Spectri clinical trials","volume":"4","author":"Chang","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ophtha.2018.09.039","article-title":"Longitudinal study of dark adaptation as a functional outcome measure for age-related macular degeneration","volume":"126","author":"Chen","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajo.2025.05.023","article-title":"Visual acuity and quality of life outcomes with pegcetacoplan treatment: a post hoc analysis from the OAKS and DERBY trials","volume":"277","author":"Chiang","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib48","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1167\/iovs.10-6034","article-title":"Improving reading speed for people with central vision loss through perceptual learning","volume":"52","author":"Chung","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2024.07.025","article-title":"The discrepancy between visual acuity decline and foveal involvement in geographic atrophy","volume":"9","author":"Cicinelli","year":"2025","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib50","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bjo.2010.190355","article-title":"Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy","volume":"95","author":"Clark","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2018.02.012","article-title":"Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints","volume":"189","author":"Cocce","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41598-024-51539-0","article-title":"Inter and intradevice assessment of microperimetry testing in aging eyes","volume":"14","author":"Coulibaly","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib58","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA ophthalmic clinical trial design and endpoints symposium","volume":"49","author":"Csaky","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib59","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1167\/iovs.17-22339","article-title":"Report from the NEI\/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases","volume":"58","author":"Csaky","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.survophthal.2019.01.014","article-title":"Microperimetry for geographic atrophy secondary to age-related macular degeneration","volume":"64","author":"Csaky","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","article-title":"Drug approval for the treatment of geographic atrophy: how we got here and where we need to go","volume":"263","author":"Csaky","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib62","article-title":"Macular tissue integrity index: a novel biomarker for geographic atrophy (GA)","author":"Csaky","year":"2024","journal-title":"ARVO Annual Meeting"},{"key":"10.1016\/j.preteyeres.2025.101421_bib63","first-page":"2438","article-title":"Use of a centrally-deployable, at-home, virtual reality perimetry test to measure lesion-customized retinal sensitivities in patients with geographic atrophy","volume":"66","author":"Csaky","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib64","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1038\/s41598-025-91627-3","article-title":"Monocular reading performance measured by MNREAD-P acuity chart in normo-readers schoolchildren","volume":"15","author":"D\u2019Almeida Souza","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib65","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.oret.2024.04.023","article-title":"Vision loss reduction with avacincaptad pegol for geographic atrophy: a 12-month post hoc analysis of the GATHER1 and GATHER2 trials","volume":"8","author":"Danzig","year":"2024","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080619","article-title":"Views and opinions of patients with glaucoma and age-related macular degeneration on vision home-monitoring: a UK-based focus group study","volume":"14","author":"Dave","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.preteyeres.2025.101421_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075713","article-title":"Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional study","volume":"14","author":"Dinah","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.preteyeres.2025.101421_bib68","first-page":"2821","article-title":"Evaluation of visual acuity measurements with standard luminance compared with low luminance in eyes with geographic atrophy from age-related macular degeneration","volume":"56","author":"Do","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41433-024-03462-x","article-title":"Photoreceptor assessment in age-related macular degeneration","volume":"39","author":"Domalpally","year":"2025","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib70","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1167\/iovs.13-11743","article-title":"Rapid and reliable assessment of the contrast sensitivity function on an iPad","volume":"54","author":"Dorr","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib71","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ophtha.2022.01.002","article-title":"From data to deployment: the collaborative community on ophthalmic imaging roadmap for artificial intelligence in age-related macular degeneration","volume":"129","author":"Dow","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib72","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/IAE.0000000000000606","article-title":"Phase II, randomized, placebo-controlled, 90-day study of emixustat HCl in geographic atrophy associated with dry age-related macular degeneration","volume":"35","author":"Dugel","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib73","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamaophthalmol.2022.2113","article-title":"Repeatability and discriminatory power of chart-based visual function tests in individuals with age-related macular degeneration: a MACUSTAR study report","volume":"140","author":"Dunbar","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100708","article-title":"Heterogeneous visual function deficits in intermediate age-related macular degeneration: a MACUSTAR report","volume":"5","author":"Dunbar","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib75","author":"Ehlers"},{"key":"10.1016\/j.preteyeres.2025.101421_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100628","article-title":"ReCLAIM-2: a randomized phase II clinical trial evaluating elamipretide in age-related macular degeneration, geographic atrophy growth, visual function, and ellipsoid zone preservation","volume":"5","author":"Ehlers","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib77","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41433-023-02571-3","article-title":"Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: a mixed-methods study","volume":"37","author":"Enoch","year":"2023","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib78","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/PPA.S386662","article-title":"Towards a therapy for geographic atrophy: a patient's experience","volume":"17","author":"Enoch","year":"2023","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.preteyeres.2025.101421_bib87","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/eye.2014.104","article-title":"Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis","volume":"28","author":"Faes","year":"2014","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.9.7.3","article-title":"Computerized adaptive tests: efficient and precise assessment of the patient-centered impact of diabetic retinopathy","volume":"9","author":"Fenwick","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib89","article-title":"Psychometric evaluation and computerized adaptive testing simulations of age-related macular degeneration quality of life item banks","volume":"14","author":"Fenwick","year":"2025","journal-title":"Asia Pac. J. Ophthalmol. (Phila.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.18502\/jovr.v17i1.10172","article-title":"Development of a spatio-temporal contrast sensitivity test for clinical use","volume":"17","author":"Fernandes Costa","year":"2022","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib91","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1167\/iovs.10-7127","article-title":"The impact of vision impairment on vision-specific quality of life in Germany","volume":"52","author":"Finger","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000491402","article-title":"MACUSTAR: development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration","volume":"241","author":"Finger","year":"2019","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101421_bib93","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00417-023-06291-y","article-title":"Test-retest repeatability and agreement of the quantitative contrast sensitivity function test: towards the validation of a new clinical endpoint","volume":"262","author":"Finn","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib95","article-title":"Individualized mesopic and dark-adapted fundus-controlled perimetry: longitudinal changes in retinal sensitivity at the border of geographic atrophy","author":"Fleckenstein","year":"2022","journal-title":"ARVO Annual Meeting,"},{"key":"10.1016\/j.preteyeres.2025.101421_bib96","author":"Fletcher"},{"key":"10.1016\/j.preteyeres.2025.101421_bib97","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1111\/aos.14571","article-title":"Full-field electroretinography in age-related macular degeneration: an overall retinal response","volume":"99","author":"Forshaw","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12886-021-01901-x","article-title":"Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration","volume":"21","author":"Forshaw","year":"2021","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib99","first-page":"1","article-title":"Low-luminance visual acuity and low-luminance deficit: optimising measurement and analysis","author":"Forte","year":"2025","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.preteyeres.2025.101421_bib100","article-title":"A deep-learning approach to identifying quantitative OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in the OAKS trial","author":"Fu","year":"2024","journal-title":"ARVO Annual Meeting,"},{"key":"10.1016\/j.preteyeres.2025.101421_bib101","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1167\/iovs.12-10734","article-title":"Clinical and microperimetric predictors of reading speed in low vision patients: a structural equation modeling approach","volume":"54","author":"Giacomelli","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100519","article-title":"Visual function measurements in eyes with diabetic retinopathy: an expert opinion on available measures","volume":"4","author":"Glassman","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib103","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/11206721221121023","article-title":"Evaluating vision-specific quality of life and functional vision in a Brazilian population with Stargardt disease","volume":"33","author":"Gomes","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10633-016-9545-y","article-title":"Electrophysiological and clinical tests in dry age-related macular degeneration follow-up: differences between mfERG and OCT","volume":"133","author":"Gonz\u00e1lez-Garc\u00eda","year":"2016","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib105","article-title":"Real-time assessment of eye movements during reading in individuals with central vision loss using eye-tracking technology: a pilot study","volume":"18","author":"Gonz\u00e1lez-Vides","year":"2025","journal-title":"J. Opt."},{"key":"10.1016\/j.preteyeres.2025.101421_bib106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/ICU.0000000000000153","article-title":"Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration","volume":"26","author":"Hanout","year":"2015","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib107","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/bjophthalmol-2021-320604","article-title":"Utilisation of composite endpoint outcome to assess efficacy of tocilizumab for non-infectious uveitis in the STOP-Uveitis study","volume":"107","author":"Hassan","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib108","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the Chroma and Spectri phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib109","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2025.101421_bib110","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1167\/iovs.17-23248","article-title":"Rapid objective assessment of contrast sensitivity and visual acuity with sweep visual evoked potentials and an extended electrode array","volume":"59","author":"Hemptinne","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243578","article-title":"Novel computer-based assessments of everyday visual function in people with age-related macular degeneration","volume":"15","author":"Higgins","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101421_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.12.7.19","article-title":"Test-retest variability and discriminatory power of measurements from microperimetry and dark adaptation assessment in people with intermediate age-related macular degeneration - a MACUSTAR study report","volume":"12","author":"Higgins","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151000","article-title":"Comparison of macular integrity assessment (MAIA\u2122), MP-3, and the Humphrey Field Analyzer in the evaluation of the relationship between the structure and function of the macula","volume":"11","author":"Hirooka","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101421_bib114","series-title":"ARVO Annual Meeting","article-title":"Precise estimation of retinal sensitivity rate in geographic atrophy using all individual test points in an optimized, patient-customized microperimetry grid","author":"Ho","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib115","article-title":"Strongest correlation between contrast sensitivity and morphological characteristics in bilateral nAMD","volume":"7","author":"Hoffmann","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib116","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101421_bib117","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/APO.0000000000000597","article-title":"Microperimetry in retinal diseases","volume":"12","author":"Horie","year":"2023","journal-title":"Asia Pac. J. Ophthalmol. (Phila.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/16.6.18","article-title":"Evaluating the performance of the quick CSF method in detecting contrast sensitivity function changes","volume":"16","author":"Hou","year":"2016","journal-title":"J. Vis."},{"key":"10.1016\/j.preteyeres.2025.101421_bib119","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12177-008-9002-6","article-title":"A short-duration dark adaptation protocol for assessment of age-related maculopathy","volume":"1","author":"Jackson","year":"2008","journal-title":"J. Ocul. Biol. Dis. Infor."},{"key":"10.1016\/j.preteyeres.2025.101421_bib120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.12.5.21","article-title":"Microperimetry reliability assessed from fixation performance","volume":"12","author":"Josan","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16855-3","article-title":"Comparison of two different contrast sensitivity devices in young adults with normal visual acuity with or without refractive surgery","volume":"12","author":"Jung","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib122","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (an AOS thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2025.101421_bib123","doi-asserted-by":"crossref","first-page":"47","DOI":"10.22599\/bioj.127","article-title":"The test-retest variability of the COMPlog system in participants with induced non-normal visual acuity","volume":"15","author":"Kan","year":"2019","journal-title":"Br. Ir. Orthopt. J."},{"key":"10.1016\/j.preteyeres.2025.101421_bib124","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vision8010008","article-title":"The influence of tear film quality on visual function","volume":"8","author":"Ka\u0161telan","year":"2024","journal-title":"Vision (Basel)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2025.101421_bib126","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1167\/iovs.16-20361","article-title":"Functional Reading Independence (FRI) index: a new patient-reported outcome measure for patients with geographic atrophy","volume":"57","author":"Kimel","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib127","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/bjophthalmol-2014-305818","article-title":"Mobile app reading speed test","volume":"99","author":"Kingsnorth","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib128","article-title":"A comprehensive review on methodologies employed for visual evoked potentials","volume":"2016","author":"Kothari","year":"2016","journal-title":"Scientifica (Cairo)."},{"key":"10.1016\/j.preteyeres.2025.101421_bib129","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1016\/j.ajo.2023.08.013","article-title":"The \"time in range\" concept in ophthalmology","volume":"256","author":"Kozak","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib130","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1038\/s41433-023-02507-x","article-title":"Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema","volume":"37","author":"Kozak","year":"2023","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib131","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bjophthalmol-2019-314949","article-title":"Core outcomes for geographic atrophy trials","volume":"104","author":"Krezel","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib132","series-title":"ARVO Annual Meeting. Fort Lauderdale,","article-title":"Characteristics of fixation in patients with geographic atrophy recorded with the MP-1 microperimeter","author":"Kroisamer","year":"2010"},{"key":"10.1016\/j.preteyeres.2025.101421_bib133","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1167\/iovs.61.5.63","article-title":"Determinants of quality of life in geographic atrophy secondary to age-related macular degeneration","volume":"61","author":"K\u00fcnzel","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib134","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jamaophthalmol.2021.3826","article-title":"Association of reading performance in geographic atrophy secondary to age-related macular degeneration with visual function and structural biomarkers","volume":"139","author":"K\u00fcnzel","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib135","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.oret.2024.01.025","article-title":"Association of lesion location and functional parameters with vision-related quality of life in geographic atrophy secondary to age-related macular degeneration","volume":"8","author":"K\u00fcnzel","year":"2024","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.12.9.7","article-title":"Reading vision in adults with early and intermediate age-related macular degeneration under mesopic and photopic conditions","volume":"12","author":"Kwon","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib137","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.9.8.7","article-title":"Clinical application of infrared-light microperimetry in the assessment of scotopic-eye sensitivity","volume":"9","author":"\u0141abuz","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib138","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ophtha.2023.05.020","article-title":"The issue of end point discordance in dry age-related macular degeneration: how might clinical trials demonstrate a functional benefit?","volume":"130","author":"Lad","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100173","article-title":"Longitudinal evaluation of visual function impairments in early and intermediate age-related macular degeneration patients","volume":"2","author":"Lad","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib140","series-title":"Macula Society","article-title":"Efficacy and safety of intravitreal administration of ANX007 in patients with geographic atrophy: results of the ARCHER phase 2 study","author":"Lad","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib141","first-page":"11","article-title":"Beneficial effects in macular function with continuous pegcetacoplan treatment: OAKS, DERBY, and GALE open-label extension","author":"Lad","year":"2024","journal-title":"Retina Society Meeting. Lisbon, Portugal"},{"key":"10.1016\/j.preteyeres.2025.101421_bib142","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-vision-101922-045110","article-title":"Informing endpoints for clinical trials of geographic atrophy","volume":"10","author":"Lad","year":"2024","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib143","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2024-001854","article-title":"New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors","volume":"9","author":"Lai","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101421_bib144","article-title":"Elamipretide-mediated visual function improvements are associated with ellipsoid zone integrity in patients with geographic atrophy","author":"Lally","year":"2023","journal-title":"ARVO Annual Meeting."},{"key":"10.1016\/j.preteyeres.2025.101421_bib145","doi-asserted-by":"crossref","first-page":"Np63","DOI":"10.1177\/11206721241310626","article-title":"Anti-complement intravitreal agents for geographic atrophy: a missed opportunity for European patients?","volume":"35","author":"Lanzetta","year":"2025","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib146","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1109\/TNSRE.2019.2953975","article-title":"Speed of rapid serial visual presentation of pictures, numbers and words affects event-related potential-based detection accuracy","volume":"28","author":"Lees","year":"2020","journal-title":"IEEE Trans. Neural Syst. Rehabil. Eng."},{"key":"10.1016\/j.preteyeres.2025.101421_bib147","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/10.3.17","article-title":"Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method","volume":"10","author":"Lesmes","year":"2010","journal-title":"J. Vis."},{"key":"10.1016\/j.preteyeres.2025.101421_bib148","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ddstr.2012.11.002","article-title":"Visual function endpoints to enable dry AMD clinical trials","volume":"10","author":"Lesmes","year":"2013","journal-title":"Drug Discov. Today Ther. Strat."},{"key":"10.1016\/j.preteyeres.2025.101421_bib149","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/08820538.2021.1900289","article-title":"Characteristics of preferred retinal locus in eyes with central vision loss secondary to different macular lesions","volume":"36","author":"Li","year":"2021","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00735-7","article-title":"Ellipsoid zone reflectivity as a functional imaging biomarker for age-related macular degeneration: a MACUSTAR study report","volume":"15","author":"Liermann","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib151","article-title":"Artificial intelligence for retinal diseases","volume":"13","author":"Lim","year":"2024","journal-title":"Asia Pac. J. Ophthalmol. (Phila.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib152","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib153","doi-asserted-by":"crossref","first-page":"BIO61","DOI":"10.1167\/iovs.16-21210","article-title":"Combined fundus autofluorescence and near infrared reflectance as prognostic biomarkers for visual acuity in foveal-sparing geographic atrophy","volume":"58","author":"Lindner","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.oret.2018.11.005","article-title":"Determinants of reading performance in eyes with foveal-sparing geographic atrophy","volume":"3","author":"Lindner","year":"2019","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib156","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00417-015-2974-6","article-title":"Retinal sensitivity is a valuable complementary measurement to visual acuity \u2013 a microperimetry study in patients with maculopathies","volume":"253","author":"Liu","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib157","series-title":"EURETINA 2024","article-title":"Visual outcomes and safety data after a single injection of AVD-104 in patients with geographic atrophy secondary to AMD in the phase 2a SIGLEC trial","author":"Loewenstein","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib158","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1167\/iovs.17-22171","article-title":"Photoreceptor layer thickness changes during dark adaptation observed with ultrahigh-resolution optical coherence tomography","volume":"58","author":"Lu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib159","article-title":"LumiThera provides update on FDA review of Valeda treatment for dry AMD patients","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib160","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archophthalmol.2012.277","article-title":"Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration","volume":"130","author":"Luu","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib161","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1167\/iovs.12-10465","article-title":"Static and flicker perimetry in age-related macular degeneration","volume":"54","author":"Luu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib162","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s10792-021-02170-9","article-title":"Role of microperimetry in evaluating disease progression in age-related macular degeneration: a scoping review","volume":"42","author":"Madheswaran","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib163","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib164","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1167\/iovs.66.3.59","article-title":"Comparison between MAIA and MP-3 in healthy subjects and patients with diabetes, diabetic retinopathy, and age-related macular degeneration","volume":"66","author":"Marmalidou","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib165","first-page":"4123","article-title":"Structure-function link between ellipsoid zone integrity features and visual acuity in eyes with geographic atrophy in the GATHER1 and GATHER2 clinical trials","volume":"66","author":"Matar","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib166","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1111\/aos.13112","article-title":"Mesopic Pelli-Robson contrast sensitivity and MP-1 microperimetry in healthy ageing and age-related macular degeneration","volume":"94","author":"Maynard","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib167","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5811\/westjem.2018.4.38383","article-title":"Understanding the use of composite endpoints in clinical trials","volume":"19","author":"McCoy","year":"2018","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV standard for full-field clinical electroretinography (2015 update)","volume":"130","author":"McCulloch","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib169","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1167\/iovs.10-6075","article-title":"Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry","volume":"52","author":"Meleth","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib170","doi-asserted-by":"crossref","DOI":"10.1136\/bjo-2024-326603","article-title":"Mapping the impact: AI-driven quantification of geographic atrophy on OCT scans and its association with visual sensitivity loss","author":"Merle","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib171","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.10.1.26","article-title":"Determinants of test variability in scotopic microperimetry: effects of dark adaptation and test indices","volume":"10","author":"Montesano","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib172","first-page":"1181","article-title":"Content validity and cognitive debriefing of a patient-reported outcome instrument evaluating symptoms and disease impact in patients with geographic atrophy","volume":"12","author":"Morga","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101421_bib173","first-page":"4145","article-title":"Meta-analysis of inter-eye concordance in bilateral geographic atrophy: implications for clinical trials","volume":"66","author":"Mori","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib174","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.14.2.7","article-title":"Structure-function relationships in geographic atrophy based on mesopic microperimetry, fundus autofluorescence, and optical coherence tomography","volume":"14","author":"Mukherjee","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100879","article-title":"Variation in mesopic retinal sensitivity relative to distance from geographic atrophy in age-related macular degeneration","volume":"5","author":"Mukherjee","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082428","article-title":"Prediction of function in ABCA4-related retinopathy using ensemble machine learning","volume":"9","author":"M\u00fcller","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100565","article-title":"Artificial intelligence-based disease activity monitoring to personalized neovascular age-related macular degeneration treatment: a feasibility study","volume":"4","author":"Mulyukov","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib178","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12886-020-01683-8","article-title":"An exploratory study to evaluate visual function endpoints in non-advanced age-related macular degeneration","volume":"20","author":"Narayanan","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib179","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/tvst.10.2.32","article-title":"The effect of test distance on visual contrast sensitivity measured using the Pelli-Robson chart","volume":"10","author":"Njeru","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2021.01.017","article-title":"Normal- and low-luminance automated quantitative contrast sensitivity assessment in eyes with age-related macular degeneration","volume":"226","author":"Ou","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib181","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archophthalmol.2009.55","article-title":"Characteristics of low-vision rehabilitation services in the United States","volume":"127","author":"Owsley","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib182","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1167\/iovs.15-18962","article-title":"Visual function in older eyes in normal macular health: association with incident early age-related macular degeneration 3 years later","volume":"57","author":"Owsley","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib183","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ophtha.2015.09.041","article-title":"Delayed rod-mediated dark adaptation is a functional biomarker for incident early age-related macular degeneration","volume":"123","author":"Owsley","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib184","article-title":"Biologically guided optimization of test target location for rod-mediated dark adaptation in age-related macular degeneration: Alabama study on early age-related macular degeneration 2 baseline. Ophthalmol","volume":"3","author":"Owsley","year":"2023","journal-title":"Sci"},{"key":"10.1016\/j.preteyeres.2025.101421_bib185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.5.5.10","article-title":"Test-retest variability of functional and structural parameters in patients with Stargardt disease participating in the SAR422459 gene therapy trial","volume":"5","author":"Parker","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib186","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1167\/iovs.08-2407","article-title":"Intersession repeatability of contrast sensitivity scores in age-related macular degeneration","volume":"50","author":"Patel","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib187","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib188","doi-asserted-by":"crossref","first-page":"7","DOI":"10.23937\/2378-346X\/1410116","article-title":"Contrast sensitivity studies and test - a review","volume":"7","author":"Pateras","year":"2020","journal-title":"Int. J. Ophthalmol. Clin. Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib189","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.visres.2013.04.015","article-title":"Measuring contrast sensitivity","volume":"90","author":"Pelli","year":"2013","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib190","author":"PeriVision"},{"key":"10.1016\/j.preteyeres.2025.101421_bib191","doi-asserted-by":"crossref","first-page":"BIO158","DOI":"10.1167\/iovs.17-21454","article-title":"Effective dynamic range and retest reliability of dark-adapted two-color fundus-controlled perimetry in patients with macular diseases","volume":"58","author":"Pfau","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib192","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/IAE.0000000000002337","article-title":"Mesopic and dark-adapted two-color fundus-controlled perimetry in geographic atrophy secondary to age-related macular degeneration","volume":"40","author":"Pfau","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib193","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2020.04.003","article-title":"Determinants of cone and rod functions in geographic atrophy: AI-based structure-function correlation","volume":"217","author":"Pfau","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib194","article-title":"Fully automated patient-tailored microperimetry: firstorbit-study report","author":"Pfau","year":"2024","journal-title":"ARVO Annual Meeting"},{"key":"10.1016\/j.preteyeres.2025.101421_bib196","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00417-018-4017-6","article-title":"Mesopic visual acuity is less crowded","volume":"256","author":"Pluhacek","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib197","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231748","article-title":"Detecting vision loss in intermediate age-related macular degeneration: a comparison of visual function tests","volume":"15","author":"Pondorfer","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101421_bib198","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.10.1.5","article-title":"Development of the Vision Impairment in Low Luminance questionnaire","volume":"10","author":"Pondorfer","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib199","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/s41433-022-02349-z","article-title":"Exploring regression to the mean in visual acuities by investigating measurements at two consecutive time points in untreated fellow eyes","volume":"37","author":"Preston","year":"2023","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib200","series-title":"47th Annual Macula Society Meeting","article-title":"Pegcetacoplan delays time to loss of central macular sensitivity: a microperimetry analysis of the phase 3 OAKS study","author":"Rachitskaya","year":"2024"},{"key":"10.1016\/j.preteyeres.2025.101421_bib201","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00417-017-3659-0","article-title":"Reading charts in ophthalmology","volume":"255","author":"Radner","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib202","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.3390\/jcm14093079","article-title":"Clinical applications of the cone contrast test in ophthalmology and neurology","volume":"14","author":"Raju","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib203","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155509","article-title":"The Impact of Vision Impairment (IVI) questionnaire; validation of the Thai-version and the implementation on vision-related quality of life in Thai rural community","volume":"11","author":"Ratanasukon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101421_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41687-020-00272-z","article-title":"Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by three-step test-interviewing","volume":"5","author":"Rausch-Koster","year":"2021","journal-title":"J. Patient Rep. Outcomes"},{"key":"10.1016\/j.preteyeres.2025.101421_bib205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/OPTH.S445755","article-title":"Considerations for the identification and management of geographic atrophy: recommendations from an expert panel","volume":"18","author":"Regillo","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib206","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.oret.2022.05.030","article-title":"The effect of pegcetacoplan treatment on photoreceptor maintenance in geographic atrophy monitored by artificial intelligence-based OCT analysis","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib207","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/opo.12862","article-title":"Comparing the CamBlobs2 contrast sensitivity test to the near Pelli-Robson contrast sensitivity test in normally-sighted young adults","volume":"41","author":"Rijal","year":"2021","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.preteyeres.2025.101421_bib208","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajo.2021.08.007","article-title":"Correlation between localized choriocapillaris perfusion and macular function in eyes with geographic atrophy","volume":"234","author":"Rinella","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib209","doi-asserted-by":"crossref","first-page":"119","DOI":"10.22599\/bioj.179","article-title":"Can visual acuity be reliably measured at home? Validation of telemedicine remote computerised visual acuity measurements","volume":"17","author":"Ritchie","year":"2021","journal-title":"Br. Ir. Orthopt. J."},{"key":"10.1016\/j.preteyeres.2025.101421_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-017-9621-y","article-title":"ISCEV guide to visual electrodiagnostic procedures","volume":"136","author":"Robson","year":"2018","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib211","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1167\/iovs.02-1100","article-title":"How sensitive to clinical change are ETDRS logMAR visual acuity measurements?","volume":"44","author":"Rosser","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib212","first-page":"169","article-title":"Reliability and sensitivity of clinical contrast sensitivity tests","volume":"2","author":"Rubin","year":"1988","journal-title":"Clin. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib213","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib214","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.65.14.13","article-title":"Longitudinal changes of visual sensitivity with geographic atrophy progression assessed by defect-mapping microperimetry","volume":"65","author":"Saeed","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100763","article-title":"Customized evaluation of progressive visual sensitivity loss in geographic atrophy to improve the power of clinical trials","volume":"5","author":"Saeed","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100856","article-title":"Targeted defect-mapping microperimetry in geographic atrophy: a sensitive functional outcome measure for intervention trials","volume":"5","author":"Saeed","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib217","doi-asserted-by":"crossref","first-page":"7876","DOI":"10.3390\/ijerph18157876","article-title":"Minimum detectable change of visual acuity measurements using ETDRS charts (Early Treatment Diabetic Retinopathy Study)","volume":"18","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.preteyeres.2025.101421_bib218","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.3390\/app14156424","article-title":"Effects of light on visual function, alertness, and cognitive performance: a computerized test assessment","volume":"14","author":"S\u00e1nchez-Lacambra","year":"2024","journal-title":"Appl. Sci. Basel"},{"key":"10.1016\/j.preteyeres.2025.101421_bib219","author":"Sapoznik"},{"key":"10.1016\/j.preteyeres.2025.101421_bib220","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/bjophthalmol-2014-305195","article-title":"A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy","volume":"98","author":"Sayegh","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib221","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101160","article-title":"Endpoints for clinical trials in ophthalmology","volume":"97","author":"Schmetterer","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib223","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.oret.2022.01.021","article-title":"Linking function and structure with ReSensNet: predicting retinal sensitivity from OCT using deep learning","volume":"6","author":"Seeb\u00f6ck","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib224","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41433-023-02843-y","article-title":"Virtual reality headsets for perimetry testing: a systematic review","volume":"38","author":"Selvan","year":"2024","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3341\/kjo.2009.23.3.164","article-title":"Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa","volume":"23","author":"Seo","year":"2009","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib226","first-page":"4786","article-title":"Unveiling an uncharted retinal landscape: OCT-guided microperimetry reveals previously undetected sensitivity patterns in geographic atrophy and iAMD","volume":"66","author":"Sepah","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib227","first-page":"119","article-title":"Comparison of Snellen and Early Treatment Diabetic Retinopathy Study charts using a computer simulation","volume":"9","author":"Shamir","year":"2016","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib228","first-page":"899","article-title":"Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis. Ophthalmol","volume":"4","author":"Shen","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib229","first-page":"2","article-title":"Topographic variation of the growth rate of geographic atrophy in nonexudative age-related macular degeneration: a systematic review and meta-analysis","volume":"61","author":"Shen","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib230","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2025.01.028","article-title":"Determinants of four-year visual acuity loss in geographic atrophy: an analysis of age-related eye disease study and age-related eye disease study 2","volume":"132","author":"Shen","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib231","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41433-024-03174-2","article-title":"Vertical and horizontal geographic atrophy \u2013 a concept to overcome the current structure-function paradox","volume":"38","author":"Siedlecki","year":"2024","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib232","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3928\/23258160-20230824-01","article-title":"Diagnosis and management of patients with geographic atrophy secondary to age-related macular degeneration: a Delphi consensus exercise","volume":"54","author":"Singh","year":"2023","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.03.006","article-title":"Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the phase 2 MAHALO study","volume":"190","author":"Sivaprasad","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib234","first-page":"115","article-title":"Living with geographic atrophy: an ethnographic study. Ophthalmol","volume":"8","author":"Sivaprasad","year":"2019","journal-title":"Ther"},{"key":"10.1016\/j.preteyeres.2025.101421_bib235","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jval.2017.02.003","article-title":"The role of patient-reported outcome measures in value-based payment reform","volume":"20","author":"Squitieri","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.preteyeres.2025.101421_bib236","article-title":"Prevention of visual acuity loss and preservation of photoreceptors by ANX007 in dry age-related macular degeneration (AMD)\/geographic atrophy (GA) in the phase 2 ARCHER trial, including in patients with less advanced disease","author":"Stanga","year":"2024","journal-title":"FLORetina ICOOR Meeting 2024."},{"key":"10.1016\/j.preteyeres.2025.101421_bib237","article-title":"Stealth BioTherapeutics announces data from ReCLAIM-2 phase 2 trial of elamipretide in geographic atrophy","year":"2022"},{"key":"10.1016\/j.preteyeres.2025.101421_bib239","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/IAE.0000000000001316","article-title":"Responsiveness of the National Eye Institute Visual Function Questionnaire-25 to visual acuity gains in patients with diabetic macular edema: evidence from the RIDE and RISE trials","volume":"37","author":"Su\u00f1er","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib240","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ajo.2005.07.040","article-title":"Long-term follow-up of fixation patterns in eyes with central scotomas from geographic atrophy that is associated with age-related macular degeneration","volume":"140","author":"Sunness","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib241","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0161-6420(96)30483-1","article-title":"Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease","volume":"103","author":"Sunness","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib242","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(97)30079-7","article-title":"Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity","volume":"104","author":"Sunness","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib243","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0161-6420(99)90340-8","article-title":"Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration","volume":"106","author":"Sunness","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib244","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","article-title":"The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials","volume":"114","author":"Sunness","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib245","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ophtha.2008.03.009","article-title":"Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration","volume":"115","author":"Sunness","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101421_bib246","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1167\/iovs.16-21122","article-title":"Searching for objects in everyday scenes: measuring performance in people with dry age-related macular degeneration","volume":"58","author":"Taylor","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib247","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00417-017-3879-3","article-title":"The effect of non-neovascular age-related macular degeneration on face recognition performance","volume":"256","author":"Taylor","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib248","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000693","article-title":"Patient-reported outcome measures in ophthalmology: too difficult to read?","volume":"6","author":"Taylor","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101421_bib249","first-page":"233","volume":"62","author":"Tedford","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib250","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bjo.86.9.1019","article-title":"Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device","volume":"86","author":"Tejeria","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib251","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000513591","article-title":"Use of composite end points in early and intermediate age-related macular degeneration clinical trials: state-of-the-art and future directions","volume":"244","author":"Terheyden","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101421_bib252","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.11.4.21","article-title":"Interviewer administration corresponds to self-administration of the vision impairment in low luminance (VILL) questionnaire","volume":"11","author":"Terheyden","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib253","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2021-320848","article-title":"Disease-specific assessment of vision impairment in low luminance in age-related macular degeneration \u2013 a MACUSTAR study report","volume":"107","author":"Terheyden","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib254","first-page":"5677","article-title":"Vision impairment in low luminance reports and progression of intermediate age-related macular degeneration in the MACUSTAR study cohort","volume":"65","author":"Terheyden","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib255","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41433-024-03568-2","article-title":"Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study","volume":"39","author":"Terheyden","year":"2025","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib256","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1167\/iovs.17-22528","article-title":"Association of low luminance questionnaire with objective functional measures in early and intermediate age-related macular degeneration","volume":"59","author":"Thompson","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib257","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/OPX.0b013e3182512b98","article-title":"Adaptive optics scanning laser ophthalmoscope-based microperimetry","volume":"89","author":"Tuten","year":"2012","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib261","article-title":"Multiple endpoints in clinical trials","year":"2022","journal-title":"Guidance for industry"},{"key":"10.1016\/j.preteyeres.2025.101421_bib259","unstructured":"U.S. Food and Drug Administration, 2025a. Approaches to assessment of overall survival in oncology clinical trials. Guidance for industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/approaches-assessment-overall-survival-oncology-clinical-trials. (Accessed 11 November 2025)."},{"key":"10.1016\/j.preteyeres.2025.101421_bib262","unstructured":"U.S. Food and Drug Administration, 2025b. Summary of basis for regulatory action - ENCELTO. https:\/\/www.fda.gov\/vaccines-blood-biologics\/center-biologics-evaluation-and-research-cber-product-approval-information\/encelto. (Accessed 11 August 2025)."},{"key":"10.1016\/j.preteyeres.2025.101421_bib263","first-page":"4790","article-title":"Reading speed in geographic atrophy: change over time and relation to patient-reported functioning","volume":"56","author":"Varma","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib264","doi-asserted-by":"crossref","first-page":"AMD195","DOI":"10.1167\/iovs.18-24238","article-title":"Maximum reading speed in patients with geographic atrophy secondary to age-related macular degeneration","volume":"59","author":"Varma","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib265","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3390\/jcm10132768","article-title":"Measuring the contrast sensitivity function in non-neovascular and neovascular age-related macular degeneration: the quantitative contrast sensitivity function test","volume":"10","author":"Vingopoulos","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib266","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bjo-2023-323507","article-title":"Towards the validation of quantitative contrast sensitivity as a clinical endpoint: correlations with vision-related quality of life in bilateral AMD","volume":"108","author":"Vingopoulos","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib267","first-page":"4398","article-title":"Quantitative contrast sensitivity longitudinal changes correlate better than visual acuity with geographic atrophy size progression in advanced dry AMD: a new clinical endpoint","volume":"65","author":"Vingopoulos","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib268","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41433-021-01503-3","article-title":"AI-based structure-function correlation in age-related macular degeneration","volume":"35","author":"von der Emde","year":"2021","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib269","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00417-016-3466-z","article-title":"Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration","volume":"255","author":"Vujosevic","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo-2023-324246","article-title":"Imaging geographic atrophy: integrating structure and function to better understand the effects of new treatments","volume":"108","author":"Vujosevic","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib271","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1167\/iovs.13-12037","article-title":"Handheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathy","volume":"54","author":"Wang","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib272","first-page":"927","article-title":"Assessment of the impact of vision impairment","volume":"43","author":"Weih","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib273","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1167\/iovs.08-2843","article-title":"The glaucoma research community and FDA look to the future: a report from the NEI\/FDA CDER glaucoma clinical trial design and endpoints symposium","volume":"50","author":"Weinreb","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib274","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archopht.120.6.774","article-title":"How does visual impairment affect performance on tasks of everyday life? The SEE project. Salisbury Eye Evaluation","volume":"120","author":"West","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40942-023-00442-3","article-title":"Quantitative cone contrast threshold testing in patients with differing pathophysiological mechanisms causing retinal diseases","volume":"9","author":"White","year":"2023","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.preteyeres.2025.101421_bib276","doi-asserted-by":"crossref","first-page":"Bio27","DOI":"10.1167\/iovs.17-21778","article-title":"Biomarkers and surrogate endpoints in drug development: a European regulatory view","volume":"58","author":"Wickstr\u00f6m","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib277","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.preteyeres.2025.101421_bib278","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ceo.12629","article-title":"Inter-device comparison of retinal sensitivity measurements: the CenterVue MAIA and the Nidek MP-1","volume":"44","author":"Wong","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib279","first-page":"70","article-title":"The use of microperimetry to detect functional progression in non-neovascular age-related macular degeneration: a systematic review","volume":"6","author":"Wong","year":"2017","journal-title":"Asia Pac. J. Ophthalmol. (Phila.)"},{"key":"10.1016\/j.preteyeres.2025.101421_bib280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/opo.12775","article-title":"Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review","volume":"41","author":"Wood","year":"2021","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.preteyeres.2025.101421_bib281","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1167\/iovs.13-11613","article-title":"Relationship between the second reflective band on optical coherence tomography and multifocal electroretinography in age-related macular degeneration","volume":"54","author":"Wu","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib282","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamaophthalmol.2014.5963","article-title":"Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib283","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1167\/iovs.14-16210","article-title":"Impact of reticular pseudodrusen on microperimetry and multifocal electroretinography in intermediate age-related macular degeneration","volume":"56","author":"Wu","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib284","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.4.3.13","article-title":"Measurement of retinal sensitivity on tablet devices in age-related macular degeneration","volume":"4","author":"Wu","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/bjophthalmol-2015-306621","article-title":"Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration","volume":"100","author":"Wu","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib286","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.8.4.16","article-title":"Performance of a defect-mapping microperimetry approach for characterizing progressive changes in deep scotomas","volume":"8","author":"Wu","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101421_bib287","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/IAE.0000000000002982","article-title":"Using microperimetry and low-luminance visual acuity to detect the onset of late age-related macular degeneration: a LEAD study report","volume":"41","author":"Wu","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib288","first-page":"36","article-title":"Visual sensitivity loss in geographic atrophy: structure-function evaluation using defect-mapping microperimetry","volume":"65","author":"Wu","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib289","article-title":"Targeted high-density microperimetry testing of nascent geographic atrophy in age-related macular degeneration. Ophthalmol","volume":"4","author":"Wu","year":"2024","journal-title":"Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib290","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1167\/iovs.65.8.44","article-title":"Microperimetry characteristics of regions with a truly nonresponding location: implications for atrophic age-related macular degeneration","volume":"65","author":"Wu","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib291","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100700","article-title":"Reading performance in geographic atrophy: comparison of different reading speed measures for capturing longitudinal changes","volume":"5","author":"Wu","year":"2025","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib292","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1167\/iovs.18-24334","article-title":"Fonts designed for macular degeneration: impact on reading","volume":"59","author":"Xiong","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib293","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/iovs.61.6.40","article-title":"Relationship between acuity and contrast sensitivity: differences due to eye disease","volume":"61","author":"Xiong","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib294","author":"Xu"},{"key":"10.1016\/j.preteyeres.2025.101421_bib295","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/opo.12877","article-title":"Investigating the discrepancy between MAIA and MP-1 microperimetry results","volume":"41","author":"Xu","year":"2021","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.preteyeres.2025.101421_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109092","article-title":"Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials","volume":"220","author":"Yaghy","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101421_bib297","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1038\/s41598-017-05294-0","article-title":"Efficient characterization and classification of contrast sensitivity functions in aging","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101421_bib298","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000515148","article-title":"Clinical perspectives and trends: microperimetry as a trial endpoint in retinal disease","volume":"244","author":"Yang","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101421_bib299","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/jpm14050543","article-title":"Ellipsoid zone integrity and visual function in dry age-related macular degeneration","volume":"14","author":"Yordi","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.preteyeres.2025.101421_bib300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.64.13.21","article-title":"Altered eye movements during reading with simulated central and peripheral visual field defects","volume":"64","author":"Yu","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101421_bib301","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.oret.2020.04.011","article-title":"Visual acuity variability: comparing discrepancies between Snellen and ETDRS measurements among subjects entering prospective trials","volume":"5","author":"Yu","year":"2021","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2025.101421_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108266","article-title":"The spatial contrast sensitivity function and its neurophysiological bases","volume":"210","author":"Zemon","year":"2023","journal-title":"Vis. Res."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:32:57Z","timestamp":1773919977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946225000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":278,"alternative-id":["S1350946225000941"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101421","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional endpoints in patients with geographic atrophy: What to consider when designing a clinical trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101421"}}